Thomas C. Abshire

Medical College of Wisconsin — United States

Medicine · Health Sciences

46h-index8.5kcitations182works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Platelet Disorders and Treatments(82), Hemophilia Treatment and Research(69), Blood Coagulation and Thrombosis Mechanisms(41), Blood groups and transfusion(29), Venous Thromboembolism Diagnosis and Management(25)

Publications179 total

Rebalancing the hemophilia teeter-totter
Blood·2025Open Access
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years
Journal of Thrombosis and Haemostasis·2024· 4 citedOpen Access
Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial
Research and Practice in Thrombosis and Haemostasis·2024· 2 citedOpen Access
A treatment bridge for infants with hemophilia
Blood·2024Open Access
Von Willebrand Factor (VWF) multiplex activity assay differentiation of type 1 von Willebrand Disease (VWD) and variant VWD
Haemophilia·2023· 1 citedOpen Access
Clinical Characteristics, Treatment, and Outcomes of Provoked Acute Cerebral Sinovenous Thrombosis in Patients <21 Years Old: Findings from the Kids-DOTT Multinational Trial
Blood·2023Open Access
Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure
Research and Practice in Thrombosis and Haemostasis·2022· 12 citedOpen Access
Evaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding
PEDIATRICS·2022· 16 citedOpen Access
Evaluation for Bleeding Disorders in Suspected Child Abuse
PEDIATRICS·2022· 21 cited
Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score
Journal of Thrombosis and Haemostasis·2022· 8 citedOpen Access
Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program
Journal of Thrombosis and Haemostasis·2022· 20 citedOpen Access
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism
JAMA·2022· 84 citedOpen Access
Screening for von Willebrand disease does not impact posttonsillectomy bleeding in a low‐risk population
Pediatric Blood & Cancer·2021· 1 citedOpen Access
Laboratory variability in the diagnosis of type 2 VWD variants
Journal of Thrombosis and Haemostasis·2020· 20 citedOpen Access
Evaluation for Bleeding Disorders in Suspected Child Abuse
American Academy of Pediatrics eBooks·2020
Evaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding
American Academy of Pediatrics eBooks·2020
Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy
Blood Advances·2020· 31 citedOpen Access
Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes
Haemophilia·2019· 8 citedOpen Access
Contributors in Predicting Severe Hemophilia A Joint Outcomes
2019
Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States
Blood·2018· 2 cited
page 1 of 9Next →

Frequent Co-authors

Marilyn J. Manco‐Johnson(10), Joan Cox Gill(8), Amy D. Shapiro(7), W. Keith Hoots(7), Diane J. Nugent(6), Jeanne M. Lusher(6), Shannon L. Carpenter(6), Donna DiMichele(5), Cindy Leissinger(5), J. Michael Soucie(5), Christine L. Kempton(5), George R. Buchanan(4), Michael Recht(4), Eric Werner(4), Roshni Kulkarni(4), Donald H. Mahoney(4), Nigel S. Key(4), James D. Anderst(4), Craig M. Kessler(4), Amy L. Dunn(4)